GLP-1RAs regulate lipid metabolism and induce autophagy through AMPK/SIRT1 pathway to improve NAFLD

Qiang Zhang1, Jingyuan Wang2, Xiaojin Hu3

  • 1Department of Gastroenterology, Yancheng Third People's Hospital (The Yancheng School of Clinical Medicine of Nanjing Medical University), Yancheng, Jiangsu Province 224000, PR China.

Abstract

Insights

Liraglutide reverses fatty liver in hepatocytes by regulating lipid metabolism and enhancing autophagy. This action occurs through the AMPK/SIRT1 pathway, offering a new therapeutic target for non-alcoholic fatty liver disease.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Endocrinology

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a significant cause of cirrhosis and liver-related mortality.
  • Current treatments for NAFLD are limited, necessitating exploration of novel therapeutic agents.
  • Glucagon-like peptide-1 receptor agonists (GLP-1RAs) show potential for NAFLD treatment, but their mechanisms require elucidation.

Purpose of the Study:

  • To investigate the therapeutic effect of liraglutide (LRG), a GLP-1RA, on hepatic steatosis.
  • To determine if LRG's effect on NAFLD involves regulating lipid metabolism and enhancing autophagy in hepatocytes.
  • To elucidate the specific molecular pathways, including AMPK/SIRT1 signaling, involved in LRG's action.

Main Methods:

  • Examined LRG's effect on fat accumulation in fatty hepatocytes.
  • Assessed LRG's impact on enzymes regulating lipid metabolism and autophagy.
  • Utilized SIRT1 knockdown in free fatty acid (FFA)-treated cells to investigate LRG's mechanism via AMPK/SIRT1 signaling.

Main Results:

  • LRG significantly reversed FFA-induced hepatocyte steatosis.
  • LRG modulated the expression of key proteins involved in lipogenesis and lipolysis (FAS, ACC1, ATGL, HSL, LAL).
  • LRG enhanced autophagy, increased SIRT1 expression, and reduced lipid accumulation in an AMPK-dependent manner, with SIRT1 knockdown diminishing these effects.

Conclusions:

  • GLP-1RAs, like LRG, may treat hepatic steatosis by modulating lipid metabolism and autophagy.
  • The AMPK/SIRT1 pathway is crucial for the therapeutic effects of LRG on NAFLD.
  • These findings suggest GLP-1RAs as a promising therapeutic strategy for NAFLD.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
308
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
205
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.2K